Wordt geladen...
Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease
BACKGROUND/AIMS: Infliximab (IFX) often loses its therapeutic effect in initial responders with inflammatory bowel disease (IBD) over time. Low serum IFX trough levels (TLs) are linked to poor clinical response and outcomes. Maintenance of optimal therapeutic IFX concentrations is important for sust...
Bewaard in:
| Gepubliceerd in: | Gut Liver |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Editorial Office of Gut and Liver
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6743797/ https://ncbi.nlm.nih.gov/pubmed/30970435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18129 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|